Lemonade Inc. (LMND) PT Lowered to $30 at Oppenheimer
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall St futures jump as Democrats sweep midterms
- CVS Health plans to split into two public companies by 2028
- UBS starts bullish coverage on Ferrari Group on luxury logistics growth
- Citi cuts Adobe rating on ’rising risk of a hard reset’
- Apple shares slip amid guidance for tightening margins, slowing services growth
Tweet
Share
E-mailGet Alerts LMND Hot Sheet
Price: $41.34 --0%
Rating Summary:
3 Buy, 7 Hold, 6 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 15 | Down: 20 | New: 12
Rating Summary:
3 Buy, 7 Hold, 6 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 15 | Down: 20 | New: 12
Join SI Premium – FREE
Oppenheimer analyst Jason Helfstein lowered the price target on Lemonade Inc. (NYSE: LMND) to $30.00 (from $35.00) while maintaining a Outperform rating.
You May Also Be Interested In
- BioMerieux (BIM:FP) (BMXMF) PT Raised to EUR100 at Piper Sandler
- LG Household & Health Care Ltd (0519000:KS) (LGHHF) PT Lowered to KRW255,000 at Macquarie
- Astera Labs (ALAB) PT Raised to $400 at RBC Capital
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
